Margareta Verdrengh
Department of Rheumatology and Inflammation Research
Göteborg University
Göteborg
Sweden
Name/email consistency: high
- The impact of substance P signalling on the development of experimental staphylococcal sepsis and arthritis. Verdrengh, M., Tarkowski, A. Scand. J. Immunol. (2008)
- Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis. Verdrengh, M., Carlsten, H., Ohlsson, C., Tarkowski, A. J. Orthop. Res. (2007)
- Rapid systemic bone resorption during the course of Staphylococcus aureus-induced arthritis. Verdrengh, M., Carlsten, H., Ohlsson, C., Tarkowski, A. J. Infect. Dis. (2006)
- Topoisomerase II inhibitors, irrespective of their chemical composition, ameliorate experimental arthritis. Verdrengh, M., Isaksson, O., Tarkowski, A. Rheumatology. (Oxford) (2005)
- Inhibition of septic arthritis by local administration of taurine chloramine, a product of activated neutrophils. Verdrengh, M., Tarkowski, A. J. Rheumatol. (2005)
- Riboflavin in innate and acquired immune responses. Verdrengh, M., Tarkowski, A. Inflamm. Res. (2005)
- Phytoestrogen genistein as an anti-staphylococcal agent. Verdrengh, M., Collins, L.V., Bergin, P., Tarkowski, A. Microbes Infect. (2004)
- IL-1 receptor-associated kinase 1 mediates protection against Staphylococcus aureus infection. Verdrengh, M., Thomas, J.A., Hultgren, O.H. Microbes Infect. (2004)
- Impact of topoisomerase II inhibition on cytokine and chemokine production. Verdrengh, M., Tarkowski, A. Inflamm. Res. (2003)
- Genistein as an anti-inflammatory agent. Verdrengh, M., Jonsson, I.M., Holmdahl, R., Tarkowski, A. Inflamm. Res. (2003)
- Total abrogation of collagen II-induced arthritis and the B cell response to type II collagen using suboptimal doses of a topoisomerase II antagonist. Verdrengh, M., Jonsson, I.M., Zaether, O., Bajtner, E., Holmdahl, R., Tarkowski, A. Ann. Rheum. Dis. (2002)